Passing validation does not guarantee success
Some systems “pass” testing and still cause deviations, rework, and audit pain. Why? Because the validation approach checks boxes, but misses operational reality.
Five lessons worth stealing
1) Scope creep without traceability. Small add-ons accumulate. If requirements and tests do not evolve with changes, your evidence becomes stale.
2) Access control treated as an afterthought. Roles and permissions are often configured late. Then teams scramble to justify who can do what. Bake access design into early validation.
3) Integrations ignored. The core app may be solid, but data moved via scripts or middleware introduces silent failures. Validate the data flow, not just the UI.
4) Over-testing low-risk areas. Teams burn time validating cosmetic features, then run out of time for critical workflows. Risk-based focus is not optional.
5) No monitoring plan. Validation evidence is a snapshot. Without monitoring (audit trail review, periodic review, vendor release note review), control degrades.
A better “definition of done”
Done means: intended use is clear, risks are controlled, evidence is traceable, users are trained, and ongoing oversight is defined. If you cannot explain how the system stays in control after go-live, you are not finished.
Run a postmortem on your last project. Identify one lesson to operationalize this month. That is how validation maturity grows.
In recent years, validation processes across the pharmaceutical industry have been undergoing a major transformation. Workflows that were traditionally managed through paper documentation, spreadsheets and manual review cycles are increasingly moving toward digital validation platforms. As a result, life sciences organizations often evaluate solutions such as Kneat, Validfor, ValGenesis, MasterControl and Veeva when modernizing validation lifecycle management and compliance documentation.
